Zacks Investment Research
19 Oct 2026, 14:55 UTC · 1h ago
Impact · against what's priced in
The article provides no new fundamental data or catalysts for Maze Therapeutics, merely aggregating existing Wall Street analyst price targets and sentiment. Because this information is a lagging indicator of current market expectations, it does not change the stock's valuation.
No priced-in read yet
What the story claims
2 claims · scored −1 bearish … +1 bullish · 0 new · 2 priced in
The mean short-term price target for Maze Therapeutics, Inc. is $61.5, representing a potential upside of 123.4% from its current price of $27.53.
Priced inanalysis of 12 existing analyst targets
So whatThe wide dispersion between the $46.00 low and $110.00 high suggests significant volatility in valuation models for the next 12 months.
More positive than 94% of claims this week
Continue reading
5 related stories
The article reports a mean analyst price target of $61.5 and a 22.3% gain over four weeks, but provides no new operational or clinical data to drive further movement.
Read from the article alone
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
There is a positive trend in earnings estimate revisions for Maze Therapeutics, indicating analysts expect better earnings than previously predicted.
Priced ingeneral analysis of estimate revisions
So whatConsistent upward revisions typically lead to an increase in the forward P/E multiple leading up to the next earnings print.
More positive than 81% of claims this week
Which stocks this story touches
More positive than 97% of ticker scores this week
The company has seen significant price gains and has very positive analyst price targets and earnings estimate revisions.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
+6.0%
$29.18 vs $27.53 close before publication (Oct 16) · not market-adjusted
MAZE chart →
